These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6471396)

  • 1. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of screening for colorectal cancer.
    Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E
    Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: new opportunities.
    Levin TR
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for colorectal carcinoma in AMHTS (automated multiphasic health testing and services)].
    Kikkawa N; Sasai H; Murai M; Mizuno S; Miyagawa S; Furota A
    Gan No Rinsho; 1983 Nov; 29(14):1644-6. PubMed ID: 6663710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract]   [Full Text] [Related]  

  • 11. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of fecal occult blood screening in automated multiphasic health testing and services.
    Nishikawa A; Okuda T; Kubota I; Azuma H; Tanaka T; Koyasu T; Kumazaki N; Iwata H; Tanaka T; Kato K
    Jpn J Clin Oncol; 1987 Jun; 17(2):107-12. PubMed ID: 3613137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer. Issues for primary care physicians.
    Realini JP
    Prim Care; 1988 Mar; 15(1):63-77. PubMed ID: 3043500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Summary of a new assessment strategy in positive occult blood tests in mass screening].
    Robra BP
    Leber Magen Darm; 1987 Apr; 17(2):113-24. PubMed ID: 3586827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult-blood screening for colorectal carcinoma: the risks.
    Frank JW
    Am J Prev Med; 1985; 1(4):25-32. PubMed ID: 3870908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer.
    McKenna RJ
    West J Med; 1983 Sep; 139(3):362-3. PubMed ID: 6636750
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.